News & Updates
Our Team has expanded!
Monday 5th October 2020
The APT team has expanded! We are excited to announce that Amandip Gill has joined APT as a Formulation/Research Scientist and we have taken on…
COVID-19 Update - We are back!
Wednesday 1st July 2020
After a short shutdown due to the current Coronavirus pandemic APT are excited to be resuming R&D and lab work! Aston University is now on the road to reopening allowing us at APT…
APT-Hale™ - The solution to all your DPI needs!
Saturday 20th June 2020
Aston Particle Technologies is delighted to announce publishing of its first Trademark - APT-Hale™. APT-Hale™ is APT's unique platform for manufacture of dry powder inhalers covering: Single, double and triple DPI formulation High dose DPI delivery (up to 50% API)…
Patents
Friday 31st January 2020
*Update January 2020 APT's first patent covering the iDPC technology has been granted in Europe. Review process is still underway in the USA, Japan and Canada and…
Best Industrial Poster Award DDL 2019!
Friday 3rd January 2020
A big congratulations to the APT team for the best industrial poster award at DDL 2019! High dose formulation of DPIs caught the judges eye's and Jas Koner…
Meet us at DDL 2019!
Tuesday 10th September 2019
Come along to stand 426 at DDL 2019 where we can show you the benefits of manufacturing your DPIs using iDPC. Put away those high shear blenders and explore the possibilities of iDPC formulated of DPIs!
Staff Promotion
Monday 1st July 2019
Congratulations to Jasdip Koner for being promoted to Project Operations Manager at APT. Jas has been with us since formation…
iDPC masterclass by Prof Afzal Mohamed
Friday 29th March 2019
Prof Afzal Mohammed will be delivering a masterclass on iDPC at Oxford Global Annual Inhalation & Respiratory Drug Delivery Congress on the 23rd…
New iDPC Processors
Wednesday 12th December 2018
Our family of equipment has increased with the delivery of 2 new iDPC benchtop processors! This will allow us to continue…
APT and Innovate UK continue successful collaboration
Saturday 1st December 2018
APT are proud to announce they are in receipt of an Innovate UK Medicines Manufacturing Grant of £0.45M working alongside Quest Healthcare to develop fixed dose combination DPIs